alexa Tyrosine - Silica Biostructures For Improved Drug Delivery Against S. Aureus
ISSN: 2327-5073

Clinical Microbiology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

3rd International Conference on Clinical Microbiology & Microbial Genomics
September 24-26, 2014 Valencia Convention Centre, Spain

Monica Cartelle Gestal, Paul Catalin Balaure, Raisa Anamaria Popa, Alexandru Mihai Grumezescu, Georgeta Voicu, Coralia Bleotu and Alina Maria Holban
ScientificTracks Abstracts: Clin Microbial
DOI: 10.4172/2327-5073.S1.013
Despite the technological progress, the rate of efficient antimicrobial drug development remains low. Due to the increasing microbial resistance rates, novel therapeutic approaches for increasing the efficiency of current drugs are needed. Here, we report the synthesis, characterization (FT-IR, XRD, SEM) and bioevaluation of a novel tyrosine-silica hybrid nanobiostructure, for the improved delivery of erytrhomycin and clotrimazol antibiotics, used in the treatment of Staphylococcus aureus infections. Antimicrobial effect was quantified by a dilution method in order to establish the MIC (minimal inhibitory concentration) of tested antibiotic loaded nanostructures. In vitro biocompatibility was assessed through fluorescence microscopy. The prepared nano-biostructure showed IR bands which were assigned to Si?O?Si (stretch mode). The prepared bio-active nanostructures have significantly improved the anti-staphylococcal activity of erytrhomycin and clotrimazol, as demonstrated by the drastic decrease of the MIC of the respective antibiotics loaded in the nanostructure. These results, correlated with a good biocompatibility of this porous structure, tested on cultured human diploid cells highlights the possibility of using this nano-carrier for the delivery of the antimicrobial substances in lower active doses, thus reducing their cytotoxicity and related side-effects.
Monica Cartelle Gestal has completed her PhD at the age of 26. Since then she has been awarded with the Barrie the la Maza postdoctoral fellow and two different Marie curie awards. The first, a FP7 for her project to study quorum sensing system, in the second she was part of a study group to develop new antibiotic targets. Now she is a Professor and P.I and she wants to join together her two passions, antibiotic resistance and quorum sensing.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version